Safety and Effectiveness of Rituximab Biosimilar CT-P10 during Routine Clinical Practice: Final Analysis of a Post-Marketing Surveillance Study in the Republic of Korea
Cho, Seok-Goo, Jo, Jae-Cheol, Jeon, Young-Woo, Kim, Dajung, Yang, Deok-Hwan, Lee, Won Sik, Choi, Yoon Seok, Yi, Jun Ho, Yoon, Dok Hyun, Kong, Jee Hyun, Choe, Jung-yoon, Kim, Sung Hyun, Ahn, Keum Young, Park, TaeHong, Park, Jeongah, Han, Sangeun
Published in Blood (15.11.2022)
Published in Blood (15.11.2022)
Get full text
Journal Article
Candidate Bevacizumab Biosimilar CT-P16 versus European Union Reference Bevacizumab in Patients with Metastatic or Recurrent Non-Small Cell Lung Cancer: A Randomized Controlled Trial
Verschraegen, Claire, Andric, Zoran, Moiseenko, Fedor, Makharadze, Tamta, Shevnya, Sergii, Oleksiienko, Alona, Yañez Ruiz, Eduardo, Kim, SungHyun, Ahn, KeumYoung, Park, TaeHong, Park, Sijin, Ju, Hana, Ohe, Yuichiro
Published in BioDrugs : clinical immunotherapeutics, biopharmaceuticals, and gene therapy (01.11.2022)
Published in BioDrugs : clinical immunotherapeutics, biopharmaceuticals, and gene therapy (01.11.2022)
Get full text
Journal Article
Six-Year Survival Outcomes for Patients with HER2-Positive Early Breast Cancer Treated with CT-P6 or Reference Trastuzumab: Observational Follow-Up Study of a Phase 3 Randomised Controlled Trial
Stebbing, Justin, Baranau, Yauheni, Baryash, Valery, Moiseyenko, Vladimir, Boliukh, Dmytro, Antone, Nicoleta, Manikhas, Alexey, Chornobai, Anatolii, Park, Taehong, Baek, Eric Hyungseok, Lee, Jaeyong, Choi, Jiin, Kim, Nahyun, Ahn, Keumyoung, Lee, Sang Joon, Kim, Sunghyun
Published in BioDrugs : clinical immunotherapeutics, biopharmaceuticals, and gene therapy (01.05.2023)
Published in BioDrugs : clinical immunotherapeutics, biopharmaceuticals, and gene therapy (01.05.2023)
Get full text
Journal Article
A non-interventional, post-marketing surveillance study evaluating the safety and effectiveness of biosimilar rituximab (CT-P10) during routine clinical practice in the Republic of Korea
Jo, Jae-Cheol, Jeon, Youngwoo, Kim, DaJung, Yang, Deok-Hwan, Lee, Won Sik, Choi, Yoon Seok, Yi, Jun Ho, Yoon, Dok Hyun, Kong, Jee Hyun, Choe, Jung-Yoon, Kim, SungHyun, Ahn, KeumYoung, Park, TaeHong, Ju, Hana, Kwon, Soonbum, Cho, Seok-Goo
Published in Expert opinion on biological therapy (03.08.2023)
Published in Expert opinion on biological therapy (03.08.2023)
Get full text
Journal Article
A Randomized, Double-Blind Trial Comparing the Pharmacokinetics of CT-P16, a Candidate Bevacizumab Biosimilar, with its Reference Product in Healthy Adult Males
Cho, Sang-Heon, Han, Seunghoon, Ghim, Jong-Lyul, Nam, Moon-Suk, Yu, Sunyoung, Park, Taehong, Kim, Sinhye, Bae, Jihun, Shin, Jae-Gook
Published in BioDrugs : clinical immunotherapeutics, biopharmaceuticals, and gene therapy (01.04.2019)
Published in BioDrugs : clinical immunotherapeutics, biopharmaceuticals, and gene therapy (01.04.2019)
Get full text
Journal Article
SELECTIVE PRETREATMENT METHOD OF RADIOACTIVE WASTE
KIM JUNHYUCK, LIM SANGHO, PARK TAEHONG, PARK JUNGHWAN, JEONG HWAKYEUNG, CHUNG KUNHO, KANG BYUNGMAN, BAE SANGEUN
Year of Publication 08.10.2021
Get full text
Year of Publication 08.10.2021
Patent
Abstract CT551: Randomized phase III study comparing the efficacy and safety of CT-P16, a new biosimilar, to reference bevacizumab (Avastin®) in patients with metastatic or recurrent non-small cell lung cancer (NSCLC)
Ohe, Yuichiro, Bondarenko, Igor, Andric, Zoran, Ostapenko, Yuriy, Ciuleanu, Tudor, Moiseenko, Fedor, Makharadze, Tamta, Shevnya, Sergii, Oleksiienko, Alona, Ruiz, Eduardo Yañez, Kim, SungHyun, Ahn, KeumYoung, Park, TaeHong, Park, Sijin, Lee, JiEun, Kim, MinJi, Verschraegen, Claire
Published in Cancer research (Chicago, Ill.) (15.06.2022)
Published in Cancer research (Chicago, Ill.) (15.06.2022)
Get full text
Journal Article